Medical center Asclepion humane medicine researches EOOD

The medical center is at the forefront of gastroenterology research, with a particular focus on ulcerative colitis. This chronic inflammatory bowel disease is characterized by inflammation and ulcers in the digestive tract, primarily affecting the colon and rectum.

• Ulcerative Colitis
• Inflammatory Bowel Disease
• Endoscopic Response Evaluation

Through rigorous clinical trials, the center is advancing the understanding of therapeutic responses and safety profiles of novel treatments, such as VE202, aiming to improve patient outcomes and quality of life.

In the realm of pharmacology, the center is conducting pivotal studies to assess the efficacy of new oral formulations for the treatment of mild-to-moderate ulcerative colitis. These studies are crucial for determining the potential of these formulations to induce remission in patients.

• Oral Mesalazine Formulation
• Clinical Remission Assessment
• Non-Inferiority Trials

The center's research contributes significantly to the development of effective pharmacological interventions, offering hope for improved therapeutic strategies in managing ulcerative colitis.